Inactivation of lipoprotein lipase occurs on the surface of THP-1 macrophages where oligomers of angiopoietin-like protein 4 are formed

Biochemical and Biophysical Research Communications

Volumn 425, Issue 2, 2012, Pages 138-143

  Makoveichuk, Elena ^a   Sukonina, Valentina ^a,c   Kroupa, Olessia ^a   Thulin, Petra ^b   Ehrenborg, Ewa ^b   Olivecrona, Thomas ^a   Olivecrona, Gunilla ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Angiopoietin like protein 4; GW501516; Lipoprotein lipase; Macrophages

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ANGIOPOIETIN LIKE PROTEIN 4; DACTINOMYCIN; DIMER; GROWTH FACTOR; LIPOPROTEIN LIPASE; MESSENGER RNA; OLIGOMER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TETRAMER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOPOIETINS; CELL LINE; CELL MEMBRANE; DACTINOMYCIN; HUMANS; LIPOPROTEIN LIPASE; MACROPHAGES; MONOCYTES; PPAR DELTA; THIAZOLES;

EID: 84865374326     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.048     Document Type: Article

References (27)

1. Goldberg I.J. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 1996, 37:693-707.
2. Pentikainen M.O., Oksjoki R., Oorni K., Kovanen P.T. Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more. Arterioscler. Thromb. Vasc. Biol. 2002, 22:211-217.
3. Yoshida K., Shimizugawa T., Ono M., Furukawa H. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 2002, 43:1770-1772.
4. Mandard S., Zandbergen F., Tan N.S., Escher P., Patsouris D., Koenig W., Kleemann R., Bakker A., Veenman F., Wahli W., Muller M., Kersten S. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J. Biol. Chem. 2004, 279:34411-34420.
5. Sukonina V., Lookene A., Olivecrona T., Olivecrona G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl. Acad. Sci. USA 2006, 103:17450-17455.
6. Mattijssen F., Kersten S. Regulation of triglyceride metabolism by Angiopoietin-like proteins. Biochim. Biophys. Acta 1821, 2012:782-789.
7. Yau M.H., Wang Y., Lam K.S., Zhang J., Wu D., Xu A. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization. J. Biol. Chem. 2009, 284:11942-11952.
8. Shan L., Yu X.C., Liu Z., Hu Y., Sturgis L.T., Miranda M.L., Liu Q. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J. Biol. Chem. 2009, 284:1419-1424.
9. Ge H., Yang G., Huang L., Motola D.L., Pourbahrami T., Li C. Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J. Biol. Chem. 2004, 279:2038-2045.
10. Yin W., Romeo S., Chang S., Grishin N.V., Hobbs H.H., Cohen J.C. Genetic variation in ANGPTL4 provides insights into protein processing and function. J. Biol. Chem. 2009, 284:13213-13222.
11. Ogata M., Tsujita M., Hossain M.A., Akita N., Gonzalez F.J., Staels B., Suzuki S., Fukutomi T., Kimura G., Yokoyama S. On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis 2009, 205:413-419.
12. Vosper H., Khoudoli G.A., Palmer C.N. The peroxisome proliferator activated receptor delta is required for the differentiation of THP-1 monocytic cells by phorbol ester. Nucl. Recept. 2003, 1:9.
13. Makoveichuk E., Castel S., Vilaro S., Olivecrona G. Lipoprotein lipase-dependent binding and uptake of low density lipoproteins by THP-1 monocytes and macrophages: possible involvement of lipid rafts. Biochim. Biophys. Acta 2004, 1686:37-49.
14. Milosavljevic D., Kontush A., Griglio S., Le Naour G., Thillet J., Chapman M.J. VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass. Biochim. Biophys. Acta 2003, 1631:51-60.
15. Glinghammar B., Skogsberg J., Hamsten A., Ehrenborg E. PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 2003, 308:361-368.
16. Markwell M.A., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 1978, 87:206-210.
17. Auwerx J.H., Deeb S., Brunzell J.D., Peng R., Chait A. Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry 1988, 27:2651-2655.
18. Koster A., Chao Y.B., Mosior M., Ford A., Gonzalez-DeWhitt P.A., Hale J.E., Li D., Qiu Y., Fraser C.C., Yang D.D., Heuer J.G., Jaskunas S.R., Eacho P. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 2005, 146:4943-4950.
19. Staiger H., Haas C., Machann J., Werner R., Weisser M., Schick F., Machicao F., Stefan N., Fritsche A., Haring H.U. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 2009, 58:579-589.
20. Kersten S., Mandard S., Tan N.S., Escher P., Metzger D., Chambon P., Gonzalez F.J., Desvergne B., Wahli W. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J. Biol. Chem. 2000, 275:28488-28493.
21. Yoon J.C., Chickering T.W., Rosen E.D., Dussault B., Qin Y., Soukas A., Friedman J.M., Holmes W.E., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol. Cell Biol. 2000, 20:5343-5349.
22. Schoonjans K., Peinado-Onsurbe J., Lefebvre A.M., Heyman R.A., Briggs M., Deeb S., Staels B., Auwerx J. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. Embo J. 1996, 15:5336-5348.
23. Osborne J.C., Bengtsson-Olivecrona G., Lee N.S., Olivecrona T. Studies on inactivation of lipoprotein lipase: role of the dimer to monomer dissociation. Biochemistry 1985, 24:5606-5611.
24. Lookene A., Chevreuil O., Ostergaard P., Olivecrona G. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics. Biochemistry 1996, 35:12155-12163.
25. Kainulainen V., Wang H., Schick C., Bernfield M. Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids. J. Biol. Chem. 1998, 273:11563-11569.
26. Chomel C., Cazes A., Faye C., Bignon M., Gomez E., Ardidie-Robouant C., Barret A., Ricard-Blum S., Muller L., Germain S., Monnot C. Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity. Faseb J. 2009, 23:940-949.
27. Lei X., Shi F., Basu D., Huq A., Routhier S., Day R., Jin W. Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity. J. Biol. Chem. 2011, 286:15747-15756.